PRME 8-K 2026-01-12

Prime Medicine, Inc. (PRME) 8-K dated 2026-01-12 — accession 0001628280-26-001773. This URL is the filing, not the PRME hub.

Prime Medicine, Inc. (PRME) is a biotechnology company listed on NASDAQ.

Prime Medicine, Inc. filed a 8-K on 2026-01-12. Accession 0001628280-26-001773.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.

Not investment advice. The PRME SEC hub lists recent forms. The stock page is the research view.